The rising prevalence in GLP-1 agonists for diabetes has sparked a debate about delivery methods : skin-applied devices versus pills . Traditionally , GLP-1 therapies were exclusively available in pill https://safaarmm407503.dbblog.net/14259459/glp-1-patches-vs-tablets-which-suitable-for-individuals